Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Clindamycin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 76 Carboplatin 65 Pemetrexed 56 Cisplatin 41 Paclitaxel 37 Specimen Handling 24 durvalumab 23 Nivolumab 21 Magnetic Resonance Spectroscopy 19 Gemcitabine 18 Docetaxel 15 osimertinib 14 Bevacizumab 13 130-nm albumin-bound paclitaxel 13 atezolizumab 11 cemiplimab 10 Cetuximab 10 Taxes 9 Radiotherapy 9 Immunoglobulin G 9 Drug Therapy 9 Radiosurgery 8 Fluorouracil 8 Disulfides 8 Biopsy 8 tislelizumab 7 amivantamab 7 Observation 7 Ipilimumab 7 Oxaliplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06120140 2026-03-13

COCOON

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡